Evolution of the Average Target: Quest Diagnostics Incorporated

Evolution of the Target Price: Quest Diagnostics Incorporated

Changes in Analyst Recommendations: Quest Diagnostics Incorporated

2a.4dan_wj9DOVy_bLQ4jT4bQ8g77HzZwsDkOpuFnNYrP0.ieHDzm-EWI05uNe2hBmqI1pUqoOiU2Jb-NwgJxVo6rnSn_WlXMRV0xSf0Q~faa8b575ae694925a6c32f7d22096e93
05-18 Baird Adjusts Price Target on Quest Diagnostics to $232 From $229, Maintains Neutral Rating MT
04-27 Rothschild & Co Redburn Adjusts Price Target on Quest Diagnostics to $233 From $224, Maintains Buy Rating MT
04-22 UBS Adjusts Quest Diagnostics Price Target to $220 From $210, Maintains Neutral Rating MT
04-22 Truist Lifts Price Target on Quest Diagnostics to $225 From $220, Keeps Hold Rating MT
04-22 Evercore ISI Adjusts Price Target on Quest Diagnostics to $225 From $210, Maintains In Line Rating MT
04-22 Jefferies Adjusts Price Target on Quest Diagnostics to $225 From $220, Maintains Buy Rating MT
04-22 Barclays Adjusts Price Target on Quest Diagnostics to $230 From $225, Maintains Overweight Rating MT
04-22 Baird Adjusts Price Target on Quest Diagnostics to $229 From $224, Maintains Neutral Rating MT
04-21 Evercore ISI Adjusts Danaher Price Target to $225 From $210, Maintains Outperform Rating MT
04-21 Jefferies Raises Quest Diagnostics Price Target to $225 From $220 MT
04-21 Leerink Partners Adjusts Price Target on Quest Diagnostics to $240 From $235, Maintains Outperform Rating MT
04-14 Baird Adjusts Price Target on Quest Diagnostics to $224 From $219, Maintains Neutral Rating MT
04-08 Evercore ISI Adjusts Price Target on Quest Diagnostics to $210 From $220, Maintains In Line Rating MT
03-10 Argus Adjusts Price Target on Quest Diagnostics to $225 From $210, Maintains Buy Rating MT
02-18 Piper Sandler Adjusts Price Target on Quest Diagnostics to $215 From $200, Maintains Neutral Rating MT
02-12 Mizuho Securities Adjusts Quest Diagnostics PT to $235 From $210, Maintains Outperform Rating MT
02-12 Rothschild & Co Redburn Adjusts Quest Diagnostics PT to $224 From $200, Maintains Buy Rating MT
02-11 Deutsche Bank Adjusts Quest Diagnostics Price Target to $205 From $178, Maintains Hold Rating MT
02-11 UBS Adjusts Price Target on Quest Diagnostics to $210 From $190, Maintains Neutral Rating MT
02-11 Jefferies & Co Adjusts Quest Diagnostics PT to $220 From $215, Maintains Buy Rating MT
02-11 Evercore ISI Adjusts Quest Diagnostics PT to $220 From $190, Maintains In Line Rating MT
02-11 Barclays Adjusts Quest Diagnostics PT to $225 From $210, Maintains Overweight Rating MT
02-11 Baird Adjusts Quest Diagnostics Price Target to $219 From $203, Maintains Neutral Rating MT
02-11 Truist Raises Price Target on Quest Diagnostics to $220 From $205, Keeps Hold Rating MT
02-10 Citigroup Adjusts Quest Diagnostics Price Target to $215 From $190, Maintains Neutral Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+7.83%
+4.47%
+21.38%
+27.37%
+24.85%
+19.55%
+34.59%
-13.17%
+4.21%
+5.64%
Average +13.67%
Weighted average by Cap. +13.00%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
207.44USD
Average target price
223.69USD
Spread / Average Target
+7.83%
High Price Target
245.00USD
Spread / Highest target
+18.11%
Low Price Target
184.00USD
Spread / Lowest Target
-11.30%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Baird
Rothschild & Co Redburn
UBS
Truist Securities
Evercore ISI
Jefferies & Co.
Barclays
Leerink Partners
Argus
Piper Sandler
Mizuho Securities
Deutsche Bank Securities
Citigroup
JPMorgan Chase
Morgan Stanley
Nephron Research
Redburn Atlantic
BofA Securities
Baptista Research
Wells Fargo Securities
Credit Suisse
KeyBanc Capital Markets
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
207.44USD
Average target price
223.69USD
Spread / Average Target
+7.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DGX Stock
  4. Consensus Quest Diagnostics Incorporated